These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers. Al-Khaifi A, Rudling M, Angelin B. Gastroenterology; 2018 Oct; 155(4):1012-1016. PubMed ID: 29928896 [Abstract] [Full Text] [Related]
12. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance. Yan X, Li P, Tang Z, Feng B. BMC Endocr Disord; 2017 Sep 25; 17(1):60. PubMed ID: 28946907 [Abstract] [Full Text] [Related]
13. Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass. Jonsson I, Bojsen-Møller KN, Kristiansen VB, Veedfald S, Wewer Albrechtsen NJ, Clausen TR, Kuhre RE, Rehfeld JF, Holst JJ, Madsbad S, Svane MS. Front Endocrinol (Lausanne); 2021 Sep 25; 12():681116. PubMed ID: 34084153 [Abstract] [Full Text] [Related]
19. Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. Hernandez GV, Smith VA, Melnyk M, Burd MA, Sprayberry KA, Edwards MS, Peterson DG, Bennet DC, Fanter RK, Columbus DA, Steibel JP, Glanz H, Immoos C, Rice MS, Santiago-Rodriguez TM, Blank J, VanderKelen JJ, Kitts CL, Piccolo BD, La Frano MR, Burrin DG, Maj M, Manjarin R. Am J Physiol Gastrointest Liver Physiol; 2020 Mar 01; 318(3):G582-G609. PubMed ID: 32003601 [Abstract] [Full Text] [Related]